FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner

Kaiping Deng,Zhen Zhang,Caifang Ren,Yaxu Liang,Xiaoxiao Gao,Yixuan Fan,Feng Wang

DOI: https://doi.org/10.1016/j.yexcr.2021.112524

IF: 4.145

2021-04-01

Experimental Cell Research

Abstract:<p>N6-Methyladenosine (m⁶A) modification is the most abundant chemical modification in mRNA, and it participates in various biological processes, such as cell differentiation and proliferation. However, little is known about the function of m⁶A demethylase fat mass and obesity-associated (FTO) in myoblast proliferation. Here, we demonstrated that knockdown of FTO can significantly inhibit myoblast proliferation and promote apoptosis. RNA sequencing analysis revealed that a lot of downregulated genes in FTO knockdown cells are associated with cell cycle and apoptosis. Furthermore, silencing FTO drastically decreased cyclin D1 (CCND1) expression through YTHDF2-mediated mRNA degradation, thereby delaying the progression of G1 phase, and leading to impaired myoblast proliferation. These findings unraveled that FTO regulates myoblast proliferation by controlling CCND1 expression in an m⁶A-YTHDF2-dependent manner, which highlights the critical roles of m⁶A modification in myoblast proliferation.</p>

oncology,cell biology